EyePoint Pharmaceuticals, Inc. Selling and Marketing Expense in USD from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
EyePoint Pharmaceuticals, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2016 to Q3 2025.
  • EyePoint Pharmaceuticals, Inc. Selling and Marketing Expense for the quarter ending September 30, 2025 was $26K, a 8.33% increase year-over-year.
  • EyePoint Pharmaceuticals, Inc. Selling and Marketing Expense for the twelve months ending September 30, 2025 was -$5.85M, a 193% decline year-over-year.
  • EyePoint Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2024 was $131K, a 98.9% decline from 2023.
  • EyePoint Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2023 was $11.7M, a 54.2% decline from 2022.
  • EyePoint Pharmaceuticals, Inc. annual Selling and Marketing Expense for 2022 was $25.5M, a 7.26% decline from 2021.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Selling and Marketing Expense, Annual (USD)
Selling and Marketing Expense, YoY Annual Growth (%)

EyePoint Pharmaceuticals, Inc. Quarterly Selling and Marketing Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$5.85M $26K +$2K +8.33% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-06
Q2 2025 -$5.85M $35K -$15K -30% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 -$5.83M $35K -$5.97M -99.4% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-08
Q4 2024 $131K -$5.94M -$6.13M -3312% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-06
Q3 2024 $6.26M $24K -$455K -95% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-06
Q2 2024 $6.71M $50K -$5.24M -99.1% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 $12M $6M +$263K +4.58% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-08
Q4 2023 $11.7M $185K -$5.73M -96.9% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-06
Q3 2023 $17.4M $479K -$5.54M -92% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $23M $5.29M -$1.6M -23.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $24.6M $5.74M -$956K -14.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $25.5M $5.92M -$1.9M -24.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-08
Q3 2022 $27.4M $6.02M -$1.36M -18.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $28.8M $6.88M +$224K +3.36% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $28.5M $6.69M +$1.03M +18.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $27.5M $7.81M +$2M +34.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 $25.5M $7.37M +$2.11M +40% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $23.4M $6.66M +$570K +9.36% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $22.8M $5.66M -$2.47M -30.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $25.3M $5.81M -$1.59M -21.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $26.9M $5.27M -$2.51M -32.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $29.4M $6.09M -$1.2M -16.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $30.6M $8.13M +$814K +11.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 $29.8M $7.4M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-12
Q3 2019 $7.78M +$4.13M +113% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $7.28M +$5.77M +382% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $7.31M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q3 2018 $3.65M +$3.65M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $1.51M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09

EyePoint Pharmaceuticals, Inc. Annual Selling and Marketing Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $131K -$11.6M -98.9% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-06
2023 $11.7M -$13.8M -54.2% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-06
2022 $25.5M -$2M -7.26% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $27.5M +$2.21M +8.74% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-10
2020 $25.3M -$4.48M -15% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $29.8M +$20.1M +208% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 $9.66M +$9.66M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $0 $0 Jul 1, 2016 Jun 30, 2017 10-KT 2019-03-18
2016 $0 Jul 1, 2015 Jun 30, 2016 10-KT 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.